HCG 5,000iu (Human Chorionic Gonadotropin)

Human Chorionic Gonadotropin (HCG) is a glycoprotein hormone that plays a pivotal role in reproductive and endocrine research. It is primarily known for its function in pregnancy, where it supports the corpus luteum and stimulates the production of progesterone, essential for maintaining the uterine lining. HCG is also utilized in various research contexts to study its effects on reproductive tissues and its potential in modulating endocrine pathways.

The 5,000 IU preparation of HCG is manufactured to meet high purity standards, ensuring reliable results in in vitro research applications. This preparation is specifically designed for research purposes and is not intended for human consumption. Volta Peptides provides HCG for research use, allowing scientists to explore its biological functions and potential applications in reproductive biology.

Research has extensively documented the role of HCG in reproductive biology, particularly in its capacity to support the corpus luteum during early pregnancy. HCG is secreted by the syncytiotrophoblast cells of the placenta and is crucial for the maintenance of progesterone production by the corpus luteum, which is necessary for a successful pregnancy (Cole, L.A., 'Biological functions of hCG and hCG-related molecules', Reproductive Biology and Endocrinology, vol. 8, 2010).

In addition to its role in pregnancy, HCG is also studied for its effects on male fertility. Studies in animal models have demonstrated that HCG can stimulate the production of testosterone by the Leydig cells in the testes, thereby influencing spermatogenesis (Veldhuis, J.D., 'Regulation of pulsatile testosterone secretion: physiological and clinical implications', Endocrine Reviews, vol. 11, no. 1, 1990).

HCG is a valuable tool in endocrine research due to its ability to interact with the luteinizing hormone/chorionic gonadotropin receptor (LHCGR). This interaction is crucial for stimulating steroidogenesis in gonadal tissues, making it a subject of interest for studies on hormonal regulation and endocrine disorders (Ascoli, M., 'The gonadotropin receptors', Endocrine Reviews, vol. 23, no. 2, 2002).

Research has also explored the potential of HCG in modulating the immune response during pregnancy. Studies suggest that HCG may play a role in immune tolerance, which is essential for preventing the maternal immune system from rejecting the fetal allograft (Arck, P.C., 'Stress and immune mediators in miscarriage', Human Reproduction Update, vol. 7, no. 4, 2001).

HCG has been studied in the context of cancer research, particularly for its role in trophoblastic diseases and certain types of testicular cancer. Elevated levels of HCG are often used as a biomarker for these conditions, aiding in diagnosis and monitoring of treatment efficacy (Stenman, U.H., 'Tumor markers in clinical practice: a review focusing on common solid cancers', Medical Principles and Practice, vol. 12, 2003).

Research has also investigated the potential of HCG in influencing tumor growth and progression. Some studies suggest that HCG may have an inhibitory effect on certain cancer cell lines, although the mechanisms remain to be fully elucidated (Cole, L.A., 'hCG, the wonder of today's science', Reproductive Biology and Endocrinology, vol. 8, 2010).

Beyond its reproductive functions, HCG has been explored in metabolic research. Studies have investigated its influence on fat metabolism, particularly in the context of weight regulation and obesity research. However, findings are mixed, and further research is needed to clarify its role and efficacy in metabolic pathways (Greenway, F.L., 'Physiological adaptations to weight loss and factors favouring weight regain', International Journal of Obesity, vol. 39, 2015).

Animal studies have also examined the effects of HCG on energy expenditure and appetite regulation, providing insights into its potential mechanisms of action in metabolic processes (Roth, J., 'The Obesity Epidemic: A Challenge for the Future', Frontiers in Endocrinology, vol. 1, 2010).